Amyl Therapeutics

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Li\u00E8ge",
        "region": null,
        "street": "Boulevard Patience et Beaujonc",
        "country": "BE",
        "postcode": "4000",
        "box_number": null,
        "street_number": "3"
      },
      "old_address": {
        "city": "Seraing",
        "region": null,
        "street": "Rue d\u00E8l Rodge Cinse",
        "country": "BE",
        "postcode": "4102",
        "box_number": null,
        "street_number": "98"
      },
      "effective_date": "2024-03-12",
      "evidence_quote": "Le conseil d\u0027administration d\u00E9cide de transf\u00E9rer le si\u00E8ge de la soci\u00E9t\u00E9 de la Rue d\u00E8l Rodge Cinse 98 \u00E0 4102 Seraing vers le Boulevard Patience et Beaujonc 3 \u00E0 4000 Li\u00E8ge. Le transfert prendra effet \u00E0 partir du 12 mars 2024."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "warrant_issuance",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-02-12",
    "filing_date": "2024-02-08",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-02-08",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "PwC",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "ADORANTE M\u00E9lanie"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "Amyl Therapeutics",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations, le rapport de l\u2019organe d\u2019administration et le rapport du commissaire",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 2000000,
      "currency": "EUR",
      "after_eur": null,
      "delta_eur": 2000000,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-09-08",
      "evidence_quote": "\u00E0 lib\u00E9rer imm\u00E9diatement \u00E0 concurrence de la totalit\u00E9 par un apport en num\u00E9raire de deux millions d\u2019euros (2.000.000,00 \u20AC) par Monsieur Evren Ucok.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 1500000.0,
      "currency": "EUR",
      "after_eur": null,
      "delta_eur": 1500000.0,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-04-04",
      "evidence_quote": "lib\u00E9rer imm\u00E9diatement \u00E0 concurrence de la totalit\u00E9 des apports en num\u00E9raire totaux d\u2019un million cinq cent mille euros (1.500.000,00 \u20AC)",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "M\u00E9lanie Adorante",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SRL PwC Reviseurs d\u0027Entreprises",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale nomme la SRL PwC Reviseurs d\u0027Entreprises, ayant son si\u00E8ge social \u00E0 1831 Diegem, Culliganlaan 5, comme commissaire pour un terme de trois ans. Cette soci\u00E9t\u00E9 d\u00E9signe Madame M\u00E9lanie Adorante, r\u00E9viseur d\u0027entreprises, pour la repr\u00E9senter et la charge de l\u0027exercice de ce mandat au nom"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "TOUNSI Amel",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-03-29",
      "evidence_quote": "L\u0027assembl\u00E9e constate qu\u0027a d\u00E8s lors \u00E9t\u00E9 nomm\u00E9e comme administrateur de la Soci\u00E9t\u00E9 avec effet au 29 mars 2021 : la soci\u00E9t\u00E9 coop\u00E9rative \u00E0 responsabilit\u00E9 limit\u00E9e NOSHAQ PARTNERS, ayant son si\u00E8ge \u00E0 4000 Li\u00E8ge, Rue Lambert-Lombard 3, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent, Madame TOUNSI Amel, domicili"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Pierre Vandepapeli\u00E8re",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0568548672",
        "name": "Vaccibio Consulting",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-03-29",
      "evidence_quote": "Le conseil d\u0027administration a d\u00E9cid\u00E9 de nommer Vaccibio Consulting, une soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e, ayant son si\u00E8ge \u00E0 5021 Namur (Boninne), Rue du Long-Sart 38, inscrite au registre des personnes morales sous le num\u00E9ro 0568.548.672, repr\u00E9sent\u00E9e de fa\u00E7on permanente par M. Pierre Vandepapeli\u00E8re,"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Florent Gros",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0734792024",
        "name": "Swissvention Partners GmbH",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-03-29",
      "evidence_quote": "Le conseil d\u0027administration a d\u00E9cid\u00E9 de nommer Swissvention Partners GmbH, une soci\u00E9t\u00E9 de droit suisse, ayant son si\u00E8ge \u00E0 4055 Basel, Strassburgerallee 107, inscrite au registre des personnes morales sous le num\u00E9ro 0734.792.024, repr\u00E9sent\u00E9e de fa\u00E7on permanente par M. Florent Gros en qualit\u00E9 de pr\u00E9si"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2021-03-29",
    "legal_form_change": false
  },
  "bedrijfsrevisor": {
    "quote": "Le rapport du r\u00E9viseur d\u0027entreprises en date du 25 mars 2021, \u00E9tabli par la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e Moore Audit, ayant son si\u00E8ge \u00E0 Schali\u00EBnstraat 3, 2000 Anvers, repr\u00E9sent\u00E9e par M. Stijn Van Hout, inscrite au registre des personnes morales sous le num\u00E9ro 0453.925.059",
    "firm_kbo": "0453.925.059",
    "firm_name": "Moore Audit",
    "ibr_number": null,
    "individual_name": "Stijn Van Hout"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  },
  "signature_regime": "joint_by_class",
  "special_mandates": [
    {
      "quote": "L\u0027assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 Ma\u00EEtre Louisa Vandepitte, Ma\u00EEtre Maxine Daems ou tout autre avocat ou collaborateur du cabinet NautaDutilh, situ\u00E9 \u00E0 1000 Bruxelles, Chauss\u00E9e de La Hulpe 120, chacun agissant s\u00E9par\u00E9ment, ainsi qu\u0027\u00E0 leurs employ\u00E9s, pr\u00E9pos\u00E9s et mandataires, avec droit de substitution, afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u0027entreprise en vue d\u0027assurer l\u0027inscription/la modification des donn\u00E9es dans la Banque Carrefour des Entreprises et, le cas \u00E9ch\u00E9ant, aupr\u00E8s de l\u0027Administration de la Taxe sur la Valeur Ajout\u00E9e.",
      "holder_kbo": null,
      "holder_name": "Ma\u00EEtre Louisa Vandepitte",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    },
    {
      "quote": "L\u0027assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 Ma\u00EEtre Louisa Vandepitte, Ma\u00EEtre Maxine Daems ou tout autre avocat ou collaborateur du cabinet NautaDutilh, situ\u00E9 \u00E0 1000 Bruxelles, Chauss\u00E9e de La Hulpe 120, chacun agissant s\u00E9par\u00E9ment, ainsi qu\u0027\u00E0 leurs employ\u00E9s, pr\u00E9pos\u00E9s et mandataires, avec droit de substitution, afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u0027entreprise en vue d\u0027assurer l\u0027inscription/la modification des donn\u00E9es dans la Banque Carrefour des Entreprises et, le cas \u00E9ch\u00E9ant, aupr\u00E8s de l\u0027Administration de la Taxe sur la Valeur Ajout\u00E9e.",
      "holder_kbo": null,
      "holder_name": "Ma\u00EEtre Maxine Daems",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    },
    {
      "quote": "L\u0027assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 Ma\u00EEtre Louisa Vandepitte, Ma\u00EEtre Maxine Daems ou tout autre avocat ou collaborateur du cabinet NautaDutilh, situ\u00E9 \u00E0 1000 Bruxelles, Chauss\u00E9e de La Hulpe 120, chacun agissant s\u00E9par\u00E9ment, ainsi qu\u0027\u00E0 leurs employ\u00E9s, pr\u00E9pos\u00E9s et mandataires, avec droit de substitution, afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u0027entreprise en vue d\u0027assurer l\u0027inscription/la modification des donn\u00E9es dans la Banque Carrefour des Entreprises et, le cas \u00E9ch\u00E9ant, aupr\u00E8s de l\u0027Administration de la Taxe sur la Valeur Ajout\u00E9e.",
      "holder_kbo": null,
      "holder_name": "NautaDutilh",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "kind": "oprichting",
  "seat": "Quai Banning 6, 4000 Li\u00E8ge",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": {
        "kbo": null,
        "name": "VACCIBIO CONSULTING"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "nominatives",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": "VACCIBIO CONSULTING",
      "contribution_type": "cash",
      "amount_paid_in_eur": 1260,
      "holder_person_name": null,
      "is_subscriber_only": false,
      "n_shares_subscribed": 315000,
      "amount_subscribed_eur": 1260,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": null,
        "name": "SWISSVENTION PARTNERS GMBH"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "nominatives",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": "SWISSVENTION PARTNERS GMBH",
      "contribution_type": "cash",
      "amount_paid_in_eur": 540,
      "holder_person_name": null,
      "is_subscriber_only": false,
      "n_shares_subscribed": 135000,
      "amount_subscribed_eur": 540,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 2000,
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "Amyl Therapeutics",
    "legal_form": "SRL"
  },
  "initial_directors": [],
  "incorporation_date": "2020-11-25",
  "post_incorporation_mandates": []
}